Joseph Freschi, MD
Neurology · Atlanta, GANPI 1063494060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 336 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,150 and has fallen 89.3% since, to $230 in 2023.
Across 336 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$739
- Biogen$552
- Teva Pharmaceuticals USA, Inc.$455
- Amgen$430
- Novartis$397
- Biohaven Pharmaceuticals, Inc.$250
- plus $3K from 33 others
What the payments were for
- Food & beverage$5,397100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 63 | $739 |
| Biogen | 38 | $552 |
| Teva Pharmaceuticals USA, Inc. | 26 | $455 |
| Amgen(2 entities) | 14 | $430 |
| Novartis | 28 | $397 |
| Biohaven Pharmaceuticals, Inc. | 13 | $250 |
| UCB, Inc. | 13 | $237 |
| EMD Serono, Inc. | 14 | $198 |
| Lilly USA, LLC | 12 | $186 |
| Harmony Biosciences LLC | 11 | $184 |
| Jazz Pharmaceuticals Inc. | 8 | $167 |
| Pfizer | 11 | $166 |
| Acadia Pharmaceuticals Inc | 11 | $165 |
| Supernus Pharmaceuticals, Inc. | 9 | $165 |
| Amneal Pharmaceuticals LLC | 11 | $161 |
| Upsher-smith Laboratories LLC | 5 | $112 |
| Kyowa Kirin, Inc. | 5 | $94 |
| Avanir Pharmaceuticals, Inc. | 6 | $86 |
| Neurelis, Inc. | 3 | $76 |
| Arbor Pharmaceuticals, Inc. | 4 | $68 |
| Eisai Inc. | 4 | $66 |
| Sanofi | 3 | $52 |
| MDD US Operations, LLC | 2 | $49 |
| Lundbeck LLC | 3 | $45 |
| Neurocrine Biosciences, Inc. | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Adamas Pharmaceuticals, Inc. | 2 | $34 |
| Currax Pharmaceuticals LLC | 2 | $34 |
| Mallinckrodt Enterprises LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $18 |
| CSL Behring | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
| Tanabe Pharma America, Inc. | 1 | $14 |
| Acorda Therapeutics, Inc | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$230
How this compares
$5,400 in reported general payments places this provider in the 65th percentile of 506 neurology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other neurology in Atlanta
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
- Douglas StuartAtlanta$493K
- Robert GilbertAtlanta$412K
- Lawrence SeidenAtlanta$272K
- Jacqueline RosenthalAtlanta$241K
- Ben ThrowerAtlanta$203K
- Jaime Hatcher MartinAtlanta$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.